Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Feasibility and Efficacy of Post-Transplant Consolidation Immunotherapy with Nivolumab Supported By the Reinfusion of Unselected Autologous Lymphocytes in Patients Affected By Relapsed/Refractory Hodgkin Lymphoma

Blood (2018) 132 (Supplement 1): 4598.

https://doi.org/10.1182/blood-2018-99-118901

Published: 2018

Journal Articles

Patient and Therapy-Related Factors Affecting the Toxicity of Pegylated-Asparaginase for the Treatment of Adult Acute Lymphoblastic Leukemia

Paola Minetto, MD, Nadia Bisso, MD, Fabio Guolo, MD, Marino Clavio, MD, Elisa Coviello, MD, Daniela Guardo, MD, Filippo Ballerini, MD, Maurizio Miglino, PhD, Roberto Massimo Lemoli, MD, Marco Gobbi, MD

Blood (2017) 130 (Supplement 1): 1297.

https://doi.org/10.1182/blood.V130.Suppl_1.1297.1297

Published: 2017

Journal Articles

Comparison of the Efficacy and Feasibility of R-CODOX-M/IVAC-R Versus Conventional R-CHOP As First Line Regimen for High Risk Diffuse Large B-Cell Lymphoma

Giulia Bartalucci, MD, Elisa Coviello, MD, Fabio Guolo, MD, Paola Minetto, MD, Massimiliano Gambella, Giulia Rivoli, MD, Daniela Guardo, MD, Filippo Ballerini, MD, Maurizio Miglino, PhD, Alberto Fabbri, MD, Roberto M Lemoli, MD, Monica Bocchia, Marco Gobbi, MD

Blood (2017) 130 (Supplement 1): 2851.

https://doi.org/10.1182/blood.V130.Suppl_1.2851.2851

Published: 2017

Journal Articles

High Prognostic Value of a 3-Genes Molecular Score in Non-High Risk Acute Promyelocytic Leukemia Treated with AIDA 2000 Protocol: A Retrospective Study from a Regional Register

Guardo Daniela, MD, Fabio Guolo, MD, Paola Minetto, MD, Marino Clavio, MD, Livia Giannoni, MD, Elisa Coviello, MD, Giordana Pastori, MD, Giulia Rivoli, MD, Filippo Ballerini, MD, Nicoletta Colombo, PhD, Raffaella Grasso, PhD, Maurizio Miglino, PhD, Roberto Massimo Lemoli, MD, Marco Gobbi, MD

Blood (2015) 126 (23): 2601.

https://doi.org/10.1182/blood.V126.23.2601.2601

Published: 2015

Journal Articles

Fludarabine, Cytarabine, Daunoxome Plus Dasatinib Has High Efficacy with an Acceptable Toxicity Profile As Either Consolidation or Salvage Regimen in Adult Philadelphia Positive Acute Lymphoblastic Leukemia Patients

Giordana Pastori, MD, Fabio Guolo, MD, Daniela Guardo, MD, Paola Minetto, MD, Marino Clavio, MD, Maurizio Miglino, PhD, Livia Giannoni, MD, Elisa Coviello, MD, Filippo Ballerini, MD, Federica Galaverna, MD, Annalisa Kunkl, PhD, Nicoletta Colombo, PhD, Raffaella Grasso, PhD, Roberto Massimo Lemoli, MD, Marco Gobbi, MD

Blood (2015) 126 (23): 4908.

https://doi.org/10.1182/blood.V126.23.4908.4908

Published: 2015

NARROW

Feasibility and Efficacy of Post-Transplant Consolidation Immunotherapy with Nivolumab Supported By the Reinfusion of Unselected Autologous Lymphocytes in Patients Affected By Relapsed/Refractory Hodgkin Lymphoma

Patient and Therapy-Related Factors Affecting the Toxicity of Pegylated-Asparaginase for the Treatment of Adult Acute Lymphoblastic Leukemia

Comparison of the Efficacy and Feasibility of R-CODOX-M/IVAC-R Versus Conventional R-CHOP As First Line Regimen for High Risk Diffuse Large B-Cell Lymphoma

High Prognostic Value of a 3-Genes Molecular Score in Non-High Risk Acute Promyelocytic Leukemia Treated with AIDA 2000 Protocol: A Retrospective Study from a Regional Register

Fludarabine, Cytarabine, Daunoxome Plus Dasatinib Has High Efficacy with an Acceptable Toxicity Profile As Either Consolidation or Salvage Regimen in Adult Philadelphia Positive Acute Lymphoblastic Leukemia Patients

Email alerts

ASH Publications

American Society of Hematology

Feasibility and Efficacy of Post-Transplant Consolidation Immunotherapy with Nivolumab Supported By the Reinfusion of Unselected Autologous Lymphocytes in Patients Affected By Relapsed/Refractory Hodgkin Lymphoma

Patient and Therapy-Related Factors Affecting the Toxicity of Pegylated-Asparaginase for the Treatment of Adult Acute Lymphoblastic Leukemia

Comparison of the Efficacy and Feasibility of R-CODOX-M/IVAC-R Versus Conventional R-CHOP As First Line Regimen for High Risk Diffuse Large B-Cell Lymphoma

High Prognostic Value of a 3-Genes Molecular Score in Non-High Risk Acute Promyelocytic Leukemia Treated with AIDA 2000 Protocol: A Retrospective Study from a Regional Register

Fludarabine, Cytarabine, Daunoxome Plus Dasatinib Has High Efficacy with an Acceptable Toxicity Profile As Either Consolidation or Salvage Regimen in Adult Philadelphia Positive Acute Lymphoblastic Leukemia Patients

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only